You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

auvi-q Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Auvi-q patents expire, and when can generic versions of Auvi-q launch?

Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. There are eighteen patents protecting this drug.

This drug has one hundred and twelve patent family members in fourteen countries.

The generic ingredient in AUVI-Q is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Auvi-q

A generic version of auvi-q was approved as epinephrine by BPI LABS on July 29^th, 2014.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for auvi-q?
What are the global sales for auvi-q?
What is Average Wholesale Price for auvi-q?

Summary for auvi-q

International Patents:	112
US Patents:	18
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	88
Patent Applications:	4,806
Drug Prices:	Drug price information for auvi-q
Drug Sales Revenues:	Drug sales revenues for auvi-q
What excipients (inactive ingredients) are in auvi-q?	auvi-q excipients list
DailyMed Link:	auvi-q at DailyMed

Drug patent expirations by year for auvi-q

Drug Prices for auvi-q

Pharmacology for auvi-q

Drug Class	Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist
Mechanism of Action	Adrenergic alpha-Agonists Adrenergic beta-Agonists

US Patents and Regulatory Information for auvi-q

auvi-q is protected by eighteen US patents.

Patents protecting auvi-q

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device and methods for delivering drugs to infants and children
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device and methods for delivering drugs to infants and children
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device configured to produce an audible output
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medical injector with compliance tracking and monitoring
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device having an electronic circuit system
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems, and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD TO TREAT SEVERE ALLERGIC EMERGENCIES IN PATIENTS WEIGHING 7.5 TO 15 KG (16.5 TO 33 LBS)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Kaleo Inc	AUVI-Q	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	201739-001	Aug 10, 2012	BX	RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Kaleo Inc	AUVI-Q	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	201739-002	Aug 10, 2012	BX	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Kaleo Inc	AUVI-Q	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	201739-001	Aug 10, 2012	BX	RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Kaleo Inc	AUVI-Q	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	201739-001	Aug 10, 2012	BX	RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Kaleo Inc	AUVI-Q	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	201739-002	Aug 10, 2012	BX	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for auvi-q

See the table below for patents covering auvi-q around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Denmark	2099434		⤷ Sign Up
United Kingdom	2440039	Devices, systems and methods for medicament delivery	⤷ Sign Up
Canada	2743303	APPAREIL ET PROCEDES POUR L'AUTO-ADMINISTRATION DE VACCINS ET D'AUTRES MEDICAMENTS (APPARATUS AND METHODS FOR SELF-ADMINISTRATION OF VACCINES AND OTHER MEDICAMENTS)	⤷ Sign Up
United Kingdom	201114400		⤷ Sign Up
Japan	7014797		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.